| |
|
|
|
Cytosorbents Corporation  
|
|
4.83 0.06 (0.01%) |
08-21 16:00 |
|
Open: |
4.77 |
Pre close: |
4.77 |
Target:
|
7.31
|
|
High: |
4.88 |
Low: |
4.52 |
Resistance:
|
6.26
7.85
|
|
Volume: |
189,413 |
Market Cap: |
156M |
Support:
|
3.68
3.06
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
4.81
 |
MACD |
MACD(12,26):
|
-0.56 |
|
MA(20): |
5.93 |
Signal(12,26,9): |
-0.43 |
|
MA(100): |
6.70 |
Stochastic Oscillator |
%K(14,3):
|
31.06  |
|
MA(250): |
8.49 |
%D(3): |
30.53 |
|
Average Volume(K) |
3-Month: |
16473
|
52-Week |
High:
|
14.95 |
|
10-Days: |
41515 |
Low: |
3.68 |
|
RSI |
RSI(14):
|
24.10 |
Change(%): |
-59.8 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.529 |
Return on Equity (ttm) |
-101.7 |
Shares Out. (M) |
32.25 |
|
EPS Est. Current Year |
-0.270 |
Return on Assets (ttm) |
-32.0 |
Shares Float (M) |
26.60 |
|
EPS Est. Next Year |
-0.280 |
PEG Ratio |
0.00 |
% Held by Insiders |
10.20 |
|
EPS Est. Next Quarter |
-0.110 |
Qtrly Rev. Growth |
8.3 |
% Held by Institutions |
27.15 |
|
Forward EPS |
-0.120 |
Gross Profit (p.s.) |
0.465 |
Shares Short (K) |
2540 |
|
Book Value (p.s.) |
0.360 |
EBITDA (p.s.) |
-0.486 |
P/E |
-9.13 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
13.42 |
|
Profit Margin |
-72.43 |
Operating Cash Flow
(M) |
-12.77 |
P/S |
213380128.00 |
|
Operating Margin |
-69.73 |
Levered Free Cash Flow
(M) |
-6.58 |
P/CF |
-12.20 |
|
|
|
|
|
|
